Immunonutrition for Diabetic Foot Ulcers

Stopped Not enough patients meeting eligibility criteria to complete the study. It took months from study initiation to enroll 1 participant in February 2023. Once it was clear it was not possible to enroll another participant, the study was terminated.

Conditions

• Diabetes Mellitus
• Diabetic Peripheral Neuropathy
• Diabetic Foot Ulcer

Interventions

• DRUG: Lovaza
• DRUG: L-Arginine Powder
• DRUG: Vitamin C

Sponsor

Prisma Health-Midlands